Drug Formulary Review Archives – June 1, 2006
June 1, 2006
View Archives Issues
-
Pharmacists should become 'immunization advocates'
With concern rising about the possibility of an influenza pandemic, pharmacists must be immunization advocates and provide pharmaceutical care that includes evaluation of immunization status, according to a Pharmacotherapy article by two members of the U.S. Army Medical Command Military Vaccine Agency. -
Staff buy-in key to USP 797 implementation
While some aspects of implementing USP 797 ended up being surprisingly easy at Bay-town, TX-based San Jacinto Methodist Hospital, and others were quite challenging, the major lesson learned from the experience was the importance of getting the staff involved and having them take ownership of the changes, according to Charles Hines, PharmD, RPh, the hospital's pharmacy clinical coordinator. -
USP 797 is the first enforceable standard
An overview of USP Chapter 797 prepared by pharmacist Mike Hurst, RPh, MBA, for pharmacy supplier Baxa Corp., says the chapter, which became effective Jan. 1, 2004, is the first enforceable standard for sterile compounding. -
Examples of USP 797 Tasks
CAPS (Central Admixture Pharmacy Services) list these examples of what it will take to comply with USP 797: -
Pegaptanib (Macugen®) Formulary Evaluation
Pegaptanib sodium injection (Macugen®) is a sterile, aqueous solution for intravitreous injection. -
News Brief
Patient safety practices resource available -
New FDA Approvals
The Joint Commission International Center for Patient Safety has launched a new "in-development" Patient Safety Practices resource on the Center's web site at www.jcipatientsafety.org/psp.